Literature DB >> 25870077

Clinical outcomes and sagittal alignment of single-level unilateral instrumented transforaminal lumbar interbody fusion with a 4 to 5-year follow-up.

Yun Liang1, Weibin Shi1,2, Chun Jiang1, Zixian Chen1, Fubing Liu1, Zhenzhou Feng3, Xiaoxing Jiang4.   

Abstract

PURPOSE: A retrospective study was designed to evaluate clinical outcomes and sagittal alignment following single-level unilateral instrumented transforaminal lumbar interbody fusion (TLIF).
METHODS: From November 2008 to December 2010, a total of 139 patients, who suffered from single-level lumbar degenerative disease, were included in this study. Forty-seven males and seventy-two females with a mean age of 57.3 years were enrolled. The average follow-up period was 51.7 months with a range of 41-66 months. The follow-up rate was 85.6 %. Thirty-one patients had diagnosis of discogenic low back pain, ten had recurrent disk herniation, thirty-four had spinal stenosis, and fourty-four had spondylolisthesis. Clinical outcomes were evaluated using the Oswestry disability index (ODI), visual analog scale (VAS) and Japanese Orthopedic Association. Operating time, blood loss, length of stay, and complications were also evaluated. The sagittal alignment and fusion status were assessed by X-ray and three-dimensional computed tomography.
RESULTS: The average operating time was 92.1 ± 27.5 min, the average blood loss was 135.1 ± 113.5 ml, and the average length of stay was 12.0 ± 2.9 days. The overall complication rate was 13.4 %, and the fusion rate was 82.4 %. The postoperative clinical outcomes and sagittal alignment were significantly different from the preoperative values. The final lumbar lordosis angle and segment lordosis angle were associated with back pain VAS and ODI scores, respectively.
CONCLUSION: Unilateral instrumented TLIF is a safe and effective treatment option for single-level lumbar degenerative disease, and is less invasive, yields good outcomes and has a low complication rate. In addition, the procedure has the potential to partly restore sagittal alignment.

Entities:  

Keywords:  Clinical outcomes; Lumbar degenerative diseases; Sagittal alignment; Transforaminal lumbar interbody fusion; Unilateral instrumentation

Mesh:

Year:  2015        PMID: 25870077     DOI: 10.1007/s00586-015-3933-y

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  25 in total

Review 1.  Adjacent segment disease after lumbar or lumbosacral fusion: review of the literature.

Authors:  Paul Park; Hugh J Garton; Vishal C Gala; Julian T Hoff; John E McGillicuddy
Journal:  Spine (Phila Pa 1976)       Date:  2004-09-01       Impact factor: 3.468

2.  Unilateral versus bilateral instrumented transforaminal lumbar interbody fusion in two-level degenerative lumbar disorders: a prospective randomised study.

Authors:  Kai Zhang; Wei Sun; Chang-qing Zhao; Hua Li; Wei Ding; You-zhuan Xie; Xiao-jiang Sun; Jie Zhao
Journal:  Int Orthop       Date:  2013-08-06       Impact factor: 3.075

3.  Unilateral versus bilateral percutaneous pedicle screw fixation in minimally invasive transforaminal lumbar interbody fusion.

Authors:  Un Yong Choi; Jeong Yoon Park; Kyung Hyun Kim; Sung Uk Kuh; Dong Kyu Chin; Keun Su Kim; Yong Eun Cho
Journal:  Neurosurg Focus       Date:  2013-08       Impact factor: 4.047

4.  Comparative study of unilateral and bilateral pedicle screw fixation in posterior lumbar interbody fusion.

Authors:  Youzhuan Xie; Hui Ma; Hua Li; Wei Ding; Changqing Zhao; Pu Zhang; Jie Zhao
Journal:  Orthopedics       Date:  2012-10       Impact factor: 1.390

5.  Restoration of lordosis and disk height after single-level transforaminal lumbar interbody fusion.

Authors:  Christopher K Kepler; Jeffrey A Rihn; Kristen E Radcliff; Amar A Patel; D Greg Anderson; Alexander R Vaccaro; Alan S Hilibrand; Todd J Albert
Journal:  Orthop Surg       Date:  2012-02       Impact factor: 2.071

6.  Correlation between sagittal plane changes and adjacent segment degeneration following lumbar spine fusion.

Authors:  M N Kumar; A Baklanov; D Chopin
Journal:  Eur Spine J       Date:  2001-08       Impact factor: 3.134

7.  Short-term outcome of bilateral decompression via a unilateral paramedian approach for transforaminal lumbar interbody fusion with unilateral pedicle screw fixation.

Authors:  Zhen-Zhou Feng; Yuan-Wu Cao; Chun Jiang; Xiao-Xing Jiang
Journal:  Orthopedics       Date:  2011-05-18       Impact factor: 1.390

8.  Position of interbody spacer in transforaminal lumbar interbody fusion: effect on 3-dimensional stability and sagittal lumbar contour.

Authors:  Antonio A Faundez; Amir A Mehbod; Chunhui Wu; Wentien Wu; Avraam Ploumis; Ensor E Transfeldt
Journal:  J Spinal Disord Tech       Date:  2008-05

9.  Radiographic results of single level transforaminal lumbar interbody fusion in degenerative lumbar spine disease: focusing on changes of segmental lordosis in fusion segment.

Authors:  Sang-Bum Kim; Taek-Soo Jeon; Youn-Moo Heo; Woo-Suk Lee; Jin-Woong Yi; Tae-Kyun Kim; Cheol-Mog Hwang
Journal:  Clin Orthop Surg       Date:  2009-11-25

10.  Pelvic incidence-lumbar lordosis mismatch predisposes to adjacent segment disease after lumbar spinal fusion.

Authors:  Dominique A Rothenfluh; Daniel A Mueller; Esin Rothenfluh; Kan Min
Journal:  Eur Spine J       Date:  2014-07-14       Impact factor: 3.134

View more
  12 in total

1.  Endoscopic Transforaminal Lumbar Interbody Fusion With a Single Oblique PEEK Cage and Posterior Supplemental Fixation.

Authors:  Álvaro Dowling; Kai-Uwe Lewandrowski
Journal:  Int J Spine Surg       Date:  2020-10-29

2.  Comparison of Clinical Outcome and Radiologic Parameters in Open TLIF Versus MIS-TLIF in Single- or Double-Level Lumbar Surgeries.

Authors:  Hitesh N Modi; Utsab Shrestha
Journal:  Int J Spine Surg       Date:  2021-09-22

3.  Failure to maintain segmental lordosis during TLIF for one-level degenerative spondylolisthesis negatively affects clinical outcome 5 years postoperatively: a prospective cohort of 57 patients.

Authors:  Matevž Kuhta; Klemen Bošnjak; Rok Vengust
Journal:  Eur Spine J       Date:  2019-01-24       Impact factor: 3.134

Review 4.  Interbody Fusions in the Lumbar Spine: A Review.

Authors:  Ravi Verma; Sohrab Virk; Sheeraz Qureshi
Journal:  HSS J       Date:  2020-01-13

Review 5.  What can we learn from long-term studies on chronic low back pain? A scoping review.

Authors:  Alisa L Dutmer; Remko Soer; André P Wolff; Michiel F Reneman; Maarten H Coppes; Henrica R Schiphorst Preuper
Journal:  Eur Spine J       Date:  2022-01-19       Impact factor: 3.134

6.  The technical feasibility and preliminary results of minimally invasive endoscopic-TLIF based on electromagnetic navigation: a case series.

Authors:  Derong Xu; Shuo Han; Chao Wang; Kai Zhu; Chuanli Zhou; Xuexiao Ma
Journal:  BMC Surg       Date:  2021-03-20       Impact factor: 2.102

7.  Comparison of Minimally Invasive and Open Transforaminal Lumbar Interbody Fusion for Lumbar Disc Herniation: A Retrospective Cohort Study.

Authors:  Jinqiu Zhao; Shujun Zhang; Xiaosong Li; Bin He; Yunsheng Ou; Dianming Jiang
Journal:  Med Sci Monit       Date:  2018-12-01

8.  Clinical, Functional, and Radiologic Outcome of Single- and Double-Level Transforaminal Lumbar Interbody Fusion in Patients with Low-Grade Spondylolisthesis.

Authors:  Keyvan Eghbal; Babak Pourabbas; Hamid Reza Abdollahpour; Reza Mousavi
Journal:  Asian J Neurosurg       Date:  2019 Jan-Mar

9.  Comparison of clinical outcomes and spino-pelvic sagittal balance in degenerative lumbar spondylolisthesis: Minimally invasive oblique lumbar interbody fusion (OLIF) versus transforaminal lumbar interbody fusion (TLIF).

Authors:  Renjie Li; Xiaofeng Shao; Xuefeng Li; Yijie Liu; Weimin Jiang
Journal:  Medicine (Baltimore)       Date:  2021-01-22       Impact factor: 1.889

10.  Cage migration after unilateral instrumented transforaminal lumbar interbody fusion and associated risk factors: a modified measurement method.

Authors:  Lixia Jin; Zixian Chen; Chun Jiang; Yuanwu Cao; Zhenzhou Feng; Xiaoxing Jiang
Journal:  J Int Med Res       Date:  2019-09-11       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.